Related Experiment Video

Updated: Mar 28, 2026

Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry
07:16

Preparation of Gynura bicolor DC samples for High-Resolution Tandem Mass Spectrometry

Published on: February 2, 2024

1.1K

[Toxicogenomics and its application in safety evaluation of traditional Chinese medicine]

Xue-ping Lian, Ni Ai, Xiao-yan Lu

    Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
    |December 16, 2015
    PubMed

    Insights

    Toxicogenomics (TGx) uses genome-wide responses to toxic agents, aiding Traditional Chinese Medicine (TCM) safety evaluation. This approach reveals toxic mechanisms, identifies biomarkers, and studies TCM compatibility for detoxification.

    Area of Science:

    • Toxicogenomics (TGx)
    • Genomics
    • Molecular Toxicology

    Context:

    • TGx analyzes genome-wide responses to toxicant exposure.
    • Altered gene expression reveals toxicant disruption of cellular processes.
    • "Omics" technologies facilitate TGx research and data interpretation.

    Purpose:

    • To review progress in TGx.
    • To focus on TGx applications in Traditional Chinese Medicine (TCM) safety evaluation.
    • To highlight TGx's role in elucidating TCM toxicity mechanisms, identifying biomarkers, and studying detoxification.

    Summary:

    • TGx assesses genome-wide cellular responses to toxic agents.
    • It aids in understanding how toxicants disrupt biological pathways.
    • TGx is increasingly valuable for evaluating TCM safety, revealing mechanisms, and finding biomarkers.

    Impact:

    • TGx provides insights into TCM toxicity mechanisms.
    • It facilitates the discovery of potential toxic biomarkers for TCM.
    • TGx aids in understanding the detoxification of TCM through compatibility studies.

    Related Concept Videos

    Toxicity Testing in Animals01:23

    Toxicity Testing in Animals

    Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
    133
    Toxicokinetics: Overview01:21

    Toxicokinetics: Overview

    Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
    151
    Drug Toxicity: Dose-Dependent Reactions01:24

    Drug Toxicity: Dose-Dependent Reactions

    Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
    162
    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
    68
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
    76
    Pharmacogenetics of Drug Metabolism: Overview01:27

    Pharmacogenetics of Drug Metabolism: Overview

    Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
    111